abstract |
Medicinal products for avoiding or reducing poisoning due to large clostridial cytotoxins (LCTs), in particular clostridial difficile cytotoxins A and B (TcdA and TcdB), have, as agents, the self-tactile properties of LCTs (large clostridial cytotoxic) Characterized by containing at least one effector, ie inhibitor or activator of protease activity. |